Hoag Digestive Health Institute has appointed Dr. Jennifer Phan, a board-certified gastroenterologist, as Medical Director of the Hoag Irvine Advanced Endoscopy Center. Dr. Phan, an expert in endoscopic and bariatric procedures, will also serve as Director of Bariatric Endoscopy and Program Director of the Advanced Endoscopy Fellowship. She specializes in treating obesity, metabolic disorders, and pancreaticobiliary diseases, utilizing advanced procedures like endoscopic sleeve gastroplasty (ESG) and endoscopic ultrasound (EUS).
Author: Abhay Panchal
Helicobacter pylori is a widespread infectious disease linked to dyspepsia, ulcers, and gastric cancer. The American College of Gastroenterology’s clinical practice guidelines recommend bismuth quadruple therapy (BQT) for 14 days as the first-line treatment, particularly when antibiotic resistance is unknown. Rifabutin triple therapy or potassium-competitive acid blocker dual therapy is suggested for patients without penicillin allergies. The guidelines also emphasize post-treatment testing for eradication, antibiotic susceptibility testing, and specific salvage treatments for persistent infections. Future research priorities are outlined to address gaps in current H. pylori management.
Colorectal cancer is the second leading cause of cancer deaths, but despite its rising rates, particularly in younger individuals, it remains underfunded and less known compared to other cancers. The Colorectal Cancer Alliance’s “Project Cure CRC” aims to invest $100 million in innovative research to tackle this issue. Recent grants fund groundbreaking studies targeting advanced CRC therapies, early detection, and treatment options for BRAF-mutated colorectal cancer. The project emphasizes urgency in research, seeking novel, effective treatments and partnerships to combat CRC.
In the latest Tech Optimist podcast, Jeff Glueck, CEO of Salvo Health, discusses their digital platform aimed at managing chronic gut and metabolic conditions like IBS. Salvo Health partners with local practices to provide patients a comprehensive care team, including dietitians and GI-trained nurses. Their app focuses on lifestyle adjustments like diet, stress management, and microbiome health, bridging the gap between doctor visits. Jeff invites gastroenterologists, particularly those in private practice, to connect with Salvo Health to expand its innovative care model.
The American Gastroenterological Association (AGA) released a Clinical Practice Update to guide the use of intestinal ultrasound (IUS) in managing inflammatory bowel disease (IBD). The update reviews IUS techniques, current use in clinical practice, and strategies to overcome implementation challenges. IUS is a noninvasive, cost-effective method for assessing disease activity in IBD patients, though it has limitations in visualizing certain areas. This update also compares IUS with other imaging and endoscopic modalities, outlining their risks, costs, and capabilities.
Odin Medical, a subsidiary of Olympus, received FDA clearance for its CADDIE™ device, the first cloud-based AI tool for detecting colorectal polyps during colonoscopies. The system enhances early cancer detection by using AI to analyze real-time video and provide visual alerts to doctors, who confirm the presence of polyps. A European clinical trial showed improved adenoma detection without increased risks. This innovation aligns with Olympus’ goal to combat rising colorectal cancer rates through advanced, cloud-connected AI technology.
Cylinder Health has appointed Jared Scharen as its new Chief Operating Officer (COO). Scharen, with a track record in scaling healthcare companies, will lead Cylinder’s operational efforts to expand its presence in digital health. His experience aligns with the company’s mission to improve patient outcomes through innovative solutions. This leadership move is part of Cylinder’s strategy to strengthen its market position and deliver value-driven healthcare services.
The article discusses combination therapy in inflammatory bowel disease (IBD), aiming to improve patient outcomes by leveraging multiple therapeutic mechanisms. While traditional combination therapies (TCT) and advanced combination therapies (ACT) show promise, challenges such as limited long-term data and safety risks remain. Studies like SONIC and UC-SUCCESS highlight the benefits of combining biologics and immunomodulators. However, more research is needed to understand the full potential and risks of combination treatments, including insurance coverage and FDA approval challenges.
The article discusses the benefits of Multidisciplinary Care Models (MCMs) for managing complex conditions like inflammatory bowel disease (IBD) and disorders of gut-brain interaction (DGBI). These models, integrating specialists from various fields, aim to improve access, quality of care, and patient outcomes. Takeda’s involvement in the One x One Summit Series Coalition is highlighted, emphasizing collaboration, data-driven research, and advocacy to promote the adoption of MCMs in gastroenterology. The initiative aims to enhance holistic care and address unmet patient needs.
A recent survey highlights a significant disconnect between employers and physicians regarding workplace quality. Nearly 38% of physicians reported a decline in workplace quality, with only 16% seeing improvement. Despite this, 82% of respondents believe maintaining a positive culture while meeting patient and market demands is possible. Physician burnout remains a critical issue, exacerbated by the COVID-19 pandemic, with nearly 63% experiencing burnout in recent years. Although the AMA reports some improvement, with burnout rates falling below 50%, the situation remains concerning. Technology and cultural changes are necessary to address these challenges and support the healthcare workforce.